American Healthcare REIT
AHR Β· Health Care REITs
$53.02
0.7%Omega Healthcare Investors
OHI Β· Health Care REITs
$46.23
0.2%The short version
- American Healthcare REIT is the larger business, with $2.3B of revenue in fiscal 2025 against $1.2B for Omega Healthcare Investors, about 1.9 times as much.
- Omega Healthcare Investors grew revenue faster (13.2%, against 9.2%).
- Investors pay more for each dollar of American Healthcare REITβs earnings: a P/E of 78.0x against 16.5x for Omega Healthcare Investors.
| Latest fiscal year | AHR Β· FY25 | OHI Β· FY25 |
|---|---|---|
| Size | ||
| Market cap | $10.2B | $14.6B |
| Revenue | $2.3B | $1.2B |
| Free cash flow | β | $798M |
| Net income | $69.8M | $590M |
| Growth | ||
| Revenue growth | 9.2% | 13.2% |
| 5-year growth | 16.2% | 5.9% |
| Share count change | 27.7% | 12.8% |
| Profitability | ||
| Gross margin | 20.6% | β |
| Operating margin | 18.4% | β |
| Net margin | 3.1% | 49.6% |
| FCF margin | β | 67.0% |
| Return on capital | β | 8.8% |
| Return on equity | 2.5% | 12.2% |
| Balance sheet | ||
| Net debt | β | $4.2B |
| Net debt / EBITDA | β | 3.6x |
| Dividends and buybacks | $164M | $780M |
| Valuation & quality | ||
| P/E | 78.0x | 16.5x |
| Piotroski F-score | β | β |
FY16
AHR $3.2M
OHI $901M
FY17
AHR $33.3M
OHI $908M
FY18
AHR $84.5M
OHI $882M
FY19
AHR $121M
OHI $929M
FY20
AHR $1.1B
OHI $892M
FY21
AHR $1.1B
OHI $1.1B
FY22
AHR $1.4B
OHI $878M
FY23
AHR $1.9B
OHI $950M
FY24
AHR $2.1B
OHI $1.1B
FY25
AHR $2.3B
OHI $1.2B
AHR
OHI
FY16
AHR β157.2%
OHI 62.2%
FY17
AHR β
OHI 34.7%
FY18
AHR β
OHI 56.4%
FY19
AHR 183.3%
OHI 59.4%
FY20
AHR 20.4%
OHI β
FY21
AHR 19.0%
OHI β
FY22
AHR 21.4%
OHI β
FY23
AHR 16.4%
OHI β
FY24
AHR 17.6%
OHI β
FY25
AHR 18.4%
OHI β
AHR
OHI
FY16
AHR β$3.6M
OHI $584M
FY17
AHR $11.3M
OHI $540M
FY18
AHR $11.2M
OHI $470M
FY19
AHR $111M
OHI $501M
FY20
AHR $211M
OHI $677M
FY21
AHR β
OHI $677M
FY22
AHR $140M
OHI $579M
FY23
AHR β
OHI $580M
FY24
AHR β
OHI $712M
FY25
AHR β
OHI $798M
AHR
OHI
FY16
AHR β
OHI 6.9%
FY17
AHR β
OHI 3.6%
FY18
AHR β
OHI 5.9%
FY19
AHR β
OHI 6.2%
FY20
AHR β
OHI 4.1%
FY21
AHR β
OHI 7.0%
FY22
AHR β
OHI 7.3%
FY23
AHR β
OHI 5.6%
FY24
AHR β
OHI 7.3%
FY25
AHR β
OHI 8.8%
AHR
OHI
Add another company
Compare up to four at once.
Each company's latest fiscal year; fiscal years end in different months. The best value in each row is highlighted where higher (or lower) is clearly better. Not investment advice.